Molecular Therapy: Difference between revisions
Content deleted Content added
No edit summary Tags: Mobile edit Mobile web edit |
No edit summary Tags: Mobile edit Mobile web edit |
||
| Line 17: | Line 17: | ||
| license = |
| license = |
||
| impact = 12.91 |
| impact = 12.91 |
||
| impact-year = |
| impact-year = 2021 |
||
| ISSNlabel = |
| ISSNlabel = |
||
| ISSN = 1525-0016 |
| ISSN = 1525-0016 |
||
Revision as of 09:26, 1 March 2023
| Discipline | Genetic diseases |
|---|---|
| Language | English |
| Edited by | Seppo Ylä-Herttuala |
| Publication details | |
| History | 2000–present |
| Publisher | |
| Frequency | Monthly |
| 12.91 (2021) | |
| Standard abbreviations | |
| ISO 4 | Mol. Ther. |
| Indexing | |
| ISSN | 1525-0016 (print) 1525-0024 (web) |
| OCLC no. | 41354718 |
| Links | |
Molecular Therapy is a scientific journal, published by Cell Press, that aims to develop and explore "molecular and cellular therapeutics to correct genetic and acquired diseases".[1]
The founder of the journal and its Editor-in-Chief in the first five years was Inder Verma.[2]
References
External links
  | This article about a genetics journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |